Singapore markets open in 8 hours 27 minutes
Straits Times Index
3,084.08 -6.23 (-0.20%) S&P 500
4,553.86 -40.77 (-0.89%) Dow
36,078.42 -167.08 (-0.46%) Nasdaq
14,103.77 -201.26 (-1.41%) Bitcoin USD
41,400.28 +1,651.26 (+4.15%) CMC Crypto 200
852.50 -6.21 (-0.72%)
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 11:10AM EST. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 28.75M |
| Enterprise value | 22.88M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 92.02 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -0.60 |
Trading information
Stock price history
| Beta (5Y monthly) | 2.35 |
| 52-week change 3 | 67.96% |
| S&P500 52-week change 3 | 14.90% |
| 52-week high 3 | 13.17 |
| 52-week low 3 | 2.11 |
| 50-day moving average 3 | 5.39 |
| 200-day moving average 3 | 6.80 |
Share statistics
| Avg vol (3-month) 3 | 12.86k |
| Avg vol (10-day) 3 | 18.02k |
| Shares outstanding 5 | 4.42M |
| Implied shares outstanding 6 | 4.44M |
| Float 8 | 4.41M |
| % held by insiders 1 | 0.31% |
| % held by institutions 1 | 17.76% |
| Shares short (14 Nov 2023) 4 | 56.67k |
| Short ratio (14 Nov 2023) 4 | 3.5 |
| Short % of float (14 Nov 2023) 4 | 1.28% |
| Short % of shares outstanding (14 Nov 2023) 4 | 1.28% |
| Shares short (prior month 12 Oct 2023) 4 | 61.71k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:30 |
| Last split date 3 | 13 Feb 2023 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2022 |
| Most-recent quarter (mrq) | 29 Sept 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -51.96% |
| Return on equity (ttm) | -224.63% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | -16.14M |
| EBITDA | -45.09M |
| Net income avi to common (ttm) | -47.46M |
| Diluted EPS (ttm) | -11.12 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 28.73M |
| Total cash per share (mrq) | 6.49 |
| Total debt (mrq) | 22.86M |
| Total debt/equity (mrq) | 7,349.08% |
| Current ratio (mrq) | 0.99 |
| Book value per share (mrq) | 0.07 |
Cash flow statement
| Operating cash flow (ttm) | -37.55M |
| Levered free cash flow (ttm) | -20.2M |
© 2023 Yahoo. All rights reserved.